Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2025)

iSpecimen has reported Asset Writedowns and Impairment over the past 5 years, most recently at $45806.0 for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $45806.0 for Q4 2025, down 62.34% from a year ago — trailing twelve months through Dec 2025 was $59863.0 (down 81.71% YoY), and the annual figure for FY2025 was $59863.0, down 81.71%.
  • Asset Writedowns and Impairment for Q4 2025 was $45806.0 at iSpecimen, up from -$3521.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for ISPC hit a ceiling of $197924.0 in Q1 2024 and a floor of -$234277.0 in Q4 2022.
  • Median Asset Writedowns and Impairment over the past 5 years was $53896.0 (2023), compared with a mean of $47997.2.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 1335.91% in 2022 and later tumbled 1519.12% in 2025.
  • iSpecimen's Asset Writedowns and Impairment stood at $127218.0 in 2021, then plummeted by 284.15% to -$234277.0 in 2022, then skyrocketed by 126.46% to $61986.0 in 2023, then soared by 96.21% to $121623.0 in 2024, then tumbled by 62.34% to $45806.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $45806.0 (Q4 2025), -$3521.0 (Q3 2025), and -$93463.0 (Q2 2025) per Business Quant data.